BlackRock, Inc. 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
BlackRock Inc. BLK |
5,930,178 6.600% |
342,643 (+6.13%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
BlackRock Inc. BLK |
5,587,535 7.100% |
2,248,066 (+67.32%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
BlackRock Inc. BLK |
3,339,469 5.200% |
3,339,469 (New Position) |
Filing |